Science & Justice 1999-01-01

A method for the rapid detection of the zopiclone degradation product 2-amino-5-chloropyridine.

J H Galloway, I D Marsh, C M Newton, A R Forrest

Index: Sci. Justice 39(4) , 253-6, (1999)

Full Text: HTML

Abstract

Zopiclone (Zimovane) is a cyclopyrrolone compound which exhibits hypnotic and sedative effects while also exhibiting anticonvulsant and muscle relaxant activities. The detection and quantification of zopiclone is difficult. It has a high molecular weight compared to most other commonly used drugs, therapeutic levels are not high, and it is unstable in nucleophilic solvents. A degradation product of zopiclone, 2-amino-5-chloropyridine (ACP) together with a method for its detection using high-performance liquid chromatography with diode array detection has been described previously. An account is presented of a simple method for the detection of ACP using gas chromatography with mass selective detection (GC/MS) which will facilitate detection of zopiclone use as part of a routine screen.


Related Compounds

  • 2-Amino-5-chloropy...

Related Articles:

Simultaneous determination of zopiclone and its degradation product and main impurity (2-amino-5-chloropyridine) by micellar liquid chromatography with time-programmed fluorescence detection: preliminary investigation for biological monitoring.

2012-10-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 907 , 49-55, (2012)]

Capillary electrophoretic enantioselective determination of zopiclone and its impurities.

2012-06-01

[Electrophoresis 33(11) , 1606-12, (2012)]

Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.

2013-01-01

[Int. J. Legal Med. 127(1) , 69-76, (2013)]

Detection of 2-amino-5-chloropyridine in urine as a parameter of zopiclone (Imovane) intake using HPLC with diode array detection.

1997-01-01

[J. Anal. Toxicol. 21(3) , 208-12, (1997)]

Stability tests of zopiclone in whole blood.

2010-07-15

[Forensic Sci. Int. 200(1-3) , 130-5, (2010)]

More Articles...